LongeVC invests in Canadian medtech Proton Intelligence
Latvian LongeVC has invested in Canadian Proton Intelligence which develops non-invasive CKM for monitoring potassium levels in patients with kidney disease. The $6,95M round also included participation from Spanish We Venture Capital, Australian Tenmile and Trampoline Venture Partners, American SOSV and Exor Ventures, Japanese 15th Rock and others.